Skip to content
Founder TaxPartners

Startup Grants and R&D Tax Relief: How They Interact

11 November 2026 · 7 min read

Get in touch

Many UK tech and product founders win both grant funding and R&D tax relief, and for years the two pulled against each other: a grant could quietly shrink the R&D claim on the work it funded. Under the merged scheme that restriction is gone. For accounting periods beginning on or after 1 April 2024, grant funding no longer reduces the qualifying R&D expenditure you can claim on that spend. If you're a grant-heavy, loss-making startup, that's worth real money, and there's still one thing you can't do.

Does a grant reduce your R&D relief claim?

Under the merged scheme, for accounting periods beginning on or after 1 April 2024, the answer is now a clear no. The merged R&D scheme removed the subsidised-expenditure restriction entirely, and HMRC's manual says the same of ERIS: "There is no restriction on subsidised expenditure" (CIRD121000). Grant funding, subsidies and customer contributions no longer cut down the qualifying R&D expenditure the way they did under the old SME scheme. A grant-funded qualifying project can be claimed in full, with one limit that has not changed: you cannot claim the same cost twice, and the grant money itself is not a claimable R&D cost.

What changed: the old subsidised-expenditure trap

Before 1 April 2024, the SME R&D scheme carried a subsidised-expenditure restriction. If a grant funded part of a qualifying project, that grant-funded spend was blocked from the more generous enhanced SME relief and pushed onto the Research and Development Expenditure Credit (RDEC) instead, which gave a materially smaller benefit. Winning an Innovate UK grant could therefore reduce the tax value of the very R&D it paid for. This forced founders into awkward modelling of whether a grant was worth taking at all.

The merged scheme scrapped that restriction. For periods beginning on or after 1 April 2024, subsidised expenditure is treated the same as self-funded spend for the R&D claim. HMRC's policy paper on the merged scheme puts it plainly: where a company receives a grant covering part of the costs of its R&D, "the amount of relief available will not be reduced." For the wider rules, see HMRC guidance on corporation tax R&D relief. The grant-versus-relief trade-off that dominated pre-2024 planning has largely dissolved.

The merged scheme, and why this matters most for ERIS

For accounting periods beginning on or after 1 April 2024, the UK has one main R&D regime: the merged scheme, giving a 20% above-the-line taxable expenditure credit. It replaces both the old SME scheme and the separate RDEC for those periods.

The bigger prize sits with loss-making startups. A loss-making SME whose relevant R&D spend is at least 30% of its total relevant expenditure (connected companies included) can access Enhanced R&D Intensive Support (ERIS): an 86% additional deduction plus a payable credit at 14.5%. Under the old rules, a grant-heavy project would have had its subsidised spend forced onto RDEC, both shrinking the claim and often dragging the company below routes it should have qualified for. Now that grant funding no longer reduces the qualifying spend, a heavily grant-funded, loss-making, R&D-intensive SME can count that full spend toward both the 30% intensity test and the enhanced deduction, and can reach ERIS where the old rules would have kept it on RDEC (relevant R&D spend for the intensity test is spend that qualifies for the extra deduction, CIRD123000). The ERIS guide works through the 30% test and the payable credit in full.

What's that worth in cash? Say your loss-making company spends £200,000 on qualifying R&D in a year, and an £80,000 grant paid for part of it. All £200,000 counts. Under the merged scheme the credit is 20%, so £40,000; as a loss-maker, notional tax at 19% (£7,600) is held back to set against future corporation tax, so up to £32,400 comes to you as cash now. If you meet the ERIS tests instead, the extra 86% deduction takes the total deduction to 186%, or £372,000. If your trading loss after that deduction is at least £372,000, surrendering it gives a payable credit of 14.5%, which is £53,940. Both figures are before the PAYE cap (£20,000 plus 300% of your PAYE and NIC for the period), so check that first if your payroll is small.

Scenarios under the merged scheme

Scenario Treatment under the merged scheme
Project is fully self-funded (no grant) If the work seeks an advance in science or technology and resolves technological uncertainty, it qualifies under the merged scheme (20% credit), or ERIS if the company is loss-making and meets the 30% R&D-intensity test.
Grant part-funds the project (match-funded) Both the grant-funded and self-funded qualifying spend can be claimed. The subsidised-expenditure restriction no longer reduces the grant-funded portion. The whole qualifying project follows the merged scheme (or ERIS if the tests are met).
Grant fully funds a discrete work package The fully grant-funded work package can still be claimed, provided it is qualifying R&D. There is no longer a separate, worse route for grant-funded spend. Keep records by work package so the qualifying spend is clearly evidenced.
Grant work is routine development, not R&D No qualifying R&D exists regardless of funding, so no relief can be claimed on this spend. The grant is irrelevant here; the work simply fails the R&D test.

Calculator

R&D Relief Estimator 2026/27

Enter your qualifying R&D expenditure and company position. The tool shows your merged-scheme net benefit and, where you qualify, the ERIS payable credit. Speak to a specialist before filing.

£

Total qualifying R&D costs for the period: staff, subcontractors or externally provided workers (EPW), software, consumables.

£

The R&D-qualifying fraction of payroll only. Must be no more than total qualifying expenditure above.

Loss-making companies with 30%+ R&D intensity may qualify for the higher ERIS payable credit.

£

Used for the 30% R&D-intensity test (ERIS). Must be greater than zero.

25% main rate, 19% small profits rate, and 26.5% on each extra £1 of profit inside the marginal relief band. Only affects the net value of the merged-scheme taxable credit for a profit-making company; a loss-making company's credit is netted at 19%.

Your result

Your answer's ready. Press below to see it.

What a grant still cannot do

Two limits survive the change. First, the work must pass the qualifying R&D test on its own merits: qualifying R&D must seek an advance in science or technology and resolve scientific or technological uncertainty. Routine software development and incremental product updates do not qualify, however they are funded. Second, you cannot claim the same cost twice: grant income is not itself a claimable R&D cost, and you claim relief on the qualifying expenditure, not on the grant.

A grant from an innovation body does not itself confirm that the funded work qualifies for R&D tax relief. The grant body applies its own assessment criteria, which are not the same as HMRC's. It is possible to win a competitive innovation grant for work that does not meet the HMRC qualifying test. It is equally possible for unfunded work to qualify while a grant-funded work package on the same project does not.

So don't treat grant funding as a proxy for R&D qualification. It's an easy mistake to make, and the qualifying test applies whatever the funder decided.

One question matters more than it used to: who decided to do the R&D? The subsidy rules went because the new contracted-out rules do that job (HM Treasury's technical note, November 2023). If a customer pays you to do R&D it decided to contract out, it's generally the customer that claims, not you, unless the customer is an "irrelievable client" such as a university or charity (CIRD161000).

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

Practical steps: before you claim

The interaction is far simpler than it used to be, but a few steps still matter.

  1. Identify the qualifying R&D, funded or not. Grant funding no longer changes whether qualifying spend can be claimed, so the work now is scoping which activity genuinely meets the R&D test, not policing which costs a grant touched.
  2. Keep grant and R&D records aligned. Maintain records that identify the qualifying spend and evidence it. You are not carving out grant-funded costs any more, but clean records still support the claim and any HMRC enquiry, and they stop the same cost being counted twice.
  3. Notify HMRC of your claim intent within the 6-month window. If you're claiming for the first time, or your last claim was made more than 3 years before the end of your claim notification period, you must tell HMRC you plan to claim. The window runs from the first day of the period of account to 6 months after that period ends. This applies regardless of whether a grant is involved, and missing the window invalidates the claim. From 1 April 2027 no claim notification form is due to be needed for claims made on or after that date (announced at Budget 2026 on 28 October 2026, still to pass in the Finance Bill). See the claim notification guide.
  4. Submit the Additional Information Form before the CT600. The Additional Information Form (AIF) is mandatory and goes in before or on the same day as the CT600. Without it, HMRC says the claim "will not be accepted", and if the return goes in first, the claim "will be rejected". HMRC plans to simplify the form from autumn 2027 (announced at Budget 2026 on 28 October 2026).

What to do next

If you turned down or under-modelled a grant in the past because it would have cut your R&D claim, that calculation has changed under the merged scheme. A grant-funded qualifying project can now be claimed in full, and a loss-making R&D-intensive SME may reach ERIS on spend the old rules would have blocked.

The R&D claims service covers qualifying-work assessment, AIF preparation and CT600 submission. For R&D-intensive loss-making companies, the ERIS guide covers the 30% intensity test and the payable credit that grant-heavy startups can now reach. The software R&D eligibility guide helps identify which parts of a technology project generate qualifying costs in the first place.

Use the R&D relief estimator to model the credit value on the qualifying spend your company expects to claim.

Frequently asked questions

Under the merged scheme, for accounting periods beginning on or after 1 April 2024, no. The subsidised-expenditure restriction was removed, so grant funding no longer cuts down the qualifying R&D expenditure you can claim. The qualifying work still has to meet the R&D test, and you cannot claim the same cost twice. Sources: HMRC's policy paper on the merged scheme (22 November 2023) and HMRC's R&D manual, CIRD121000 for ERIS.

The merged scheme removed the subsidised-expenditure restriction that used to reduce grant-funded R&D. So a grant-funded qualifying project can be claimed in full under the merged scheme, subject to not double-counting the same cost. This is a change from the pre-April 2024 SME rules, where a grant often pushed spend onto the lower-value RDEC route.

Before 1 April 2024, under the SME scheme, expenditure subsidised by a grant could not get the enhanced SME relief and was instead pushed onto RDEC, which gave a smaller benefit. The merged scheme scrapped that restriction, so subsidised spend is now treated the same as self-funded spend for the R&D claim.

Yes. Because the merged scheme removed the subsidised-expenditure restriction, a heavily grant-funded, loss-making, R&D-intensive SME that the old rules would have forced onto RDEC can now qualify for ERIS, provided its relevant R&D spend is at least 30% of its total relevant expenditure (connected companies included). ERIS gives an 86% additional deduction plus a 14.5% payable credit.

Under the merged scheme an Innovate UK grant no longer reduces the R&D claim on the funded spend, because the subsidised-expenditure restriction was removed for periods beginning on or after 1 April 2024. The funded work still has to meet the qualifying R&D test, and the grant funding itself is not a claimable cost.

No. Qualifying R&D must seek an advance in science or technology and resolve genuine technological uncertainty. Routine development does not qualify regardless of how it is funded. A grant funds the project; it does not change whether the underlying work meets the R&D test.

Need specialist startup tax advice?

Speak to an accountant who works with funded and scaling UK startups. R&D relief, SEIS/EIS, EMI, founder salary and dividend planning.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)

Related reading